HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner statement on the UN cloning debate

Washington, DC -- A statement from Dr. Alan I. Leshner, CEO of the American Association for the Advancement of Science and executive publisher of the journal Science, on the debate over research cloning that is scheduled to begin at the United Nations on Thursday 21 October 2004:

"We realize that this issue generates intense debate. We have long opposed human cloning to produce babies as dangerous and irresponsible. But we believe that nuclear cell transplantation research - what is called research or therapeutic cloning - holds the potential to ease tremendous suffering and prolong life for countless millions of people. For that reason, this window of scientific and eventual clinical opportunity should not be shut prematurely.

"These positions are reflected in the measure sponsored by Belgium-a measure that clearly represents the mainstream of scientific and medical thinking in the United States and worldwide."


'"/>

Contact: Ginger Pinholster
gpinhols@aaas.org
202-326-6421
American Association for the Advancement of Science
20-Oct-2004


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research
5. Science academies issue statements on energy efficiency, innovation
6. AAAS releases video and first board consensus statement on climate change
7. Draft environmental impact statement prepared for USAMRIID facilities at Fort Detrick
8. Environmental impact statement planned for USAMRIID facilities at Fort Detrick
9. The AIUM releases new statement regarding keepsake imaging
10. AGU statement on future of Earth and space science research at NASA
11. Amgens decision to block reinstatement of GDNF is faulted by a leading Parkinsons advocacy group

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, ... industry and the third highest quality portfolio following Seres Health and Nestle, as ... Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and ...
(Date:3/14/2019)... , ... March 13, 2019 , ... Bode Technology (Bode), a leading provider ... on more than 100,000 sexual assault kits. As thousands of untested kits are identified ... sexual assault kit backlogs . Bode has tested more than 50,000 kits in the ...
(Date:3/12/2019)... SANTA CLARA, Calif. (PRWEB) , ... March 12, ... ... world leader in strong multi-factor authentication and combined technology all-in-one smart cards, announced ... combined with FIDO strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... WHITEHOUSE, N.J. (PRWEB) , ... March 19, 2019 , ... ... and is a great opportunity to see the most cutting-edge cancer research. The Visikol ... work with 3D cell culture assays as well as their digital ...
(Date:3/19/2019)... ... ... will review strategies for data management in modular and adaptive clinical trials. , Participants will:, ... 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster , ... reducing risk and impact on trial success, trial teams, and trial execution , ...
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... DESERT, Calif. (PRWEB) , ... March 14, 2019 ... ... issued a press release announcing that its Canadian partner, the Eye Machine Canada ... Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , ...
Breaking Biology Technology:
Cached News: